Notably, genetic or pharmacologic inhibition of HDAC6 has been found to exert neuroprotective effects in ischemia stroke,14, 15 Huntington's disease,16, 17 Alzheimer's Disease,17 and hemorrhagic stroke.18, 19. Here, HDAC6 is linked to early-onset autosomal dominant Alzheimer disease.